BioNexus Gene Lab Corp

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, BioNexus Gene Lab Corp had 1.34M in cash and cash equivalents.

BioNexus Gene Lab Corp reported 637.86K in total liabilities as of the latest reported quarter, including 520.96K in current liabilities and 116.90K in non-current liabilities.

As of the latest reported quarter, BioNexus Gene Lab Corp's total assets were 9.25M, consisting of 5.45M in current assets and 3.80M in non-current assets.

BioNexus Gene Lab Corp reported 8.61M in total shareholders' equity as of the latest reported quarter.